Cost-effectiveness of Fecal Microbiota Transplantation for First Recurrent Clostridioides difficile Infection.

Elizabeth S AbyByron P VaughnEva A EnnsRadha Rajasingham

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)

FMT is a cost-effective strategy for first recurrent CDI. Prospective evaluation of FMT for first recurrent CDI is warranted to determine the efficacy and risk of recurrence.

Keyphrases

clostridium difficile
stem cells
bone marrow